Clinical Usage of the Adjuvanted Herpes Zoster Subunit Vaccine (HZ/su): Revaccination of Recipients of Live Attenuated Zoster Vaccine and Coadministration With a Seasonal Influenza Vaccine | Zendy

Michael N. Oxman | Zendy; Ruth Harbecke | Zendy; David M. Koelle | Zendy

Open Access

Clinical Usage of the Adjuvanted Herpes Zoster Subunit Vaccine (HZ/su): Revaccination of Recipients of Live Attenuated Zoster Vaccine and Coadministration With a Seasonal Influenza Vaccine

Author(s) -

Michael N. Oxman,

Ruth Harbecke,

David M. Koelle

Publication year - 2017

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1093/infdis/jix484

Subject(s) - medicine , virology , attenuated vaccine , influenza vaccine , vaccination , seasonal influenza , live attenuated influenza vaccine , immunology , covid-19 , virulence , biology , disease , gene , biochemistry , infectious disease (medical specialty)

Michael N. Oxman,1,2 Ruth Harbecke,1,3 and David M. Koelle4,5,6 1Department of Medicine, Division of Infectious Diseases, University of California, San Diego, La Jolla; 2Medicine Service, Infectious Diseases Section and 3Research Service, Veterans Affairs San Diego Healthcare System, California; and 4Departments of Medicine, Laboratory Medicine, and Global Health, University of Washington, 5Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, and 6Benaroya Research Institute, Seattle, Washington

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research